{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:20:14Z","timestamp":1794277214065,"version":"4.9.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Burkholderia pseudomallei<\/jats:italic> (<jats:italic>Bp<\/jats:italic>) and <jats:italic>Burkholderia mallei<\/jats:italic> (<jats:italic>Bm<\/jats:italic>), the etiologic agents of melioidosis and glanders, respectively, cause severe disease in both humans and animals. Studies have highlighted the importance of <jats:italic>Bp<\/jats:italic> and <jats:italic>Bm<\/jats:italic> lipopolysaccharides (LPS) as vaccine candidates. Here we describe the synthesis of seven oligosaccharides as the minimal structures featuring all of the reported acetylation\/methylation patterns associated with <jats:italic>Bp<\/jats:italic> and <jats:italic>Bm<\/jats:italic> LPS O-antigens (OAgs). Our approach is based on the conversion of an <jats:sc>l<\/jats:sc>-rhamnose into a 6-deoxy-<jats:sc>l<\/jats:sc>-talose residue at a late stage of the synthetic sequence. Using biochemical and biophysical methods, we demonstrate the binding of several <jats:italic>Bp<\/jats:italic> and <jats:italic>Bm<\/jats:italic> LPS-specific monoclonal antibodies with terminal OAg residues. Mice immunized with terminal disaccharide\u2013CRM197 constructs produced high-titer antibody responses that crossreacted with <jats:italic>Bm<\/jats:italic>-like OAgs. Collectively, these studies serve as foundation for the development of novel therapeutics, diagnostics, and vaccine candidates to combat diseases caused by <jats:italic>Bp<\/jats:italic> and <jats:italic>Bm<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/s41467-017-00173-8","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T21:01:57Z","timestamp":1500325317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens"],"prefix":"10.1038","volume":"8","author":[{"given":"Marielle","family":"Tamigney Kenfack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelina","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapat","family":"Nualnoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abba","family":"Ngassimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bl\u00e9riot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Marrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitisak","family":"Sintiprungrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narisara","family":"Chantratita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Silipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"AuCoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary N.","family":"Burtnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"173_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro1385","volume":"4","author":"WJ Wiersinga","year":"2006","unstructured":"Wiersinga, W. J., van der Poll, T., White, N. J., Day, N. P. & Peacock, S. J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. \n                           4, 272\u2013282 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"173_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0034-1398389","volume":"36","author":"BJ Currie","year":"2015","unstructured":"Currie, B. J. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin. Respir. Crit. Care. Med. \n                           36, 111\u2013125 (2015).","journal-title":"Semin. Respir. Crit. Care. Med."},{"key":"173_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2015.8","volume":"1","author":"D Limmathurotsakul","year":"2016","unstructured":"Limmathurotsakul, D. et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat. Microbiol \n                           1, 1\u20135 (2016).","journal-title":"Nat. Microbiol"},{"key":"173_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1865-1682.2012.01342.x","volume":"60","author":"I Khan","year":"2013","unstructured":"Khan, I. et al. Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures. Transbound. Emerg. Dis. \n                           60, 204\u2013221 (2013).","journal-title":"Transbound. Emerg. Dis."},{"key":"173_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/CMR.00033-15","volume":"29","author":"E Wagar","year":"2016","unstructured":"Wagar, E. Bioterrorism and the role of the clinical microbiology laboratory. Clin. Microbiol. Rev. \n                           29, 175\u2013189 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"173_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1586\/14760584.7.9.1357","volume":"7","author":"S Bondi","year":"2008","unstructured":"Bondi, S. & Goldberg, J. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei. Expert Rev. Vaccines \n                           7, 1357\u20131365 (2008).","journal-title":"Expert Rev. Vaccines"},{"key":"173_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/QCO.0b013e328322e727","volume":"22","author":"WJ Wiersinga","year":"2009","unstructured":"Wiersinga, W. J. & van der Poll, T. Immunity to Burkholderia pseudomallei. Curr. Opin. Infect. Dis. \n                           22, 102\u2013108 (2009).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"173_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.clinthera.2010.07.020","volume":"32","author":"M Sarkar-Tyson","year":"2010","unstructured":"Sarkar-Tyson, M. & Titball, R. W. Progress toward development of vaccines against melioidosis: a review. Clin. Ther. \n                           32, 1437\u20131445 (2010).","journal-title":"Clin. Ther."},{"key":"173_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/eri.10.4","volume":"8","author":"DM Estes","year":"2010","unstructured":"Estes, D. M., Dow, S. W., Schweizer, H. P. & Torres, A. G. Present and future therapeutic strategies for melioidosis and glanders. Expert Rev. Anti. Infect. Ther. \n                           8, 325\u2013338 (2010).","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"173_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fmicb.2011.00198","volume":"2","author":"N Patel","year":"2011","unstructured":"Patel, N. et al. Development of vaccines against Burkholderia pseudomallei. Front. Microbiol \n                           2, 198 (2011).","journal-title":"Front. Microbiol"},{"key":"173_CR11","doi-asserted-by":"publisher","first-page":"e1488","DOI":"10.1371\/journal.pntd.0001488","volume":"6","author":"SJ Peacock","year":"2012","unstructured":"Peacock, S. J. et al. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes. PLoS Negl. Trop. Dis. \n                           6, e1488 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"173_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcimb.2013.00005","volume":"3","author":"LC Choh","year":"2013","unstructured":"Choh, L. C. et al. Burkholderia vaccines: are we moving forward? Front. Cell Infect. Microbiol. \n                           3, 5 (2013).","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"173_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcimb.2013.00010","volume":"3","author":"EB Silva","year":"2013","unstructured":"Silva, E. B. & Dow, S. W. Development of Burkholderia mallei and pseudomallei vaccines. Front. Cell Infect. Microbiol. \n                           3, 10 (2013).","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"173_CR14","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2174\/0929867322666150408111304","volume":"22","author":"WT Casey","year":"2015","unstructured":"Casey, W. T. & McClean, S. Exploiting molecular virulence determinants in Burkholderia to develop vaccine antigens. Curr. Med. Chem. \n                           22, 1719\u20131733 (2015).","journal-title":"Curr. Med. Chem."},{"key":"173_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2958.2006.05519.x","volume":"63","author":"PJ Brett","year":"2007","unstructured":"Brett, P. J. et al. Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol. Microbiol. \n                           63, 379\u2013390 (2007).","journal-title":"Mol. Microbiol."},{"key":"173_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2172-9-46","volume":"9","author":"TE West","year":"2008","unstructured":"West, T. E., Ernst, R. K., Jansson-Hutson, M. J. & Skerrett, S. J. Activation of Toll-like receptors by Burkholderia pseudomallei. BMC Immunol. \n                           9, 46 (2008).","journal-title":"BMC Immunol."},{"key":"173_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1574-6968.1996.tb08086.x","volume":"137","author":"M Matsuura","year":"1996","unstructured":"Matsuura, M., Kawahara, K., Ezaki, T. & Nakano, M. Biological activities of lipopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. FEMS. Microbiol. Lett. \n                           137, 79\u201383 (1996).","journal-title":"FEMS. Microbiol. Lett."},{"key":"173_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1046\/j.1365-2958.1998.01139.x","volume":"30","author":"D DeShazer","year":"1998","unstructured":"DeShazer, D., Brett, P. & Woods, D. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. \n                           30, 1081\u20131100 (1998).","journal-title":"Mol. Microbiol."},{"key":"173_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1574-695X.2009.00574.x","volume":"56","author":"C Wikraiphat","year":"2009","unstructured":"Wikraiphat, C. et al. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants. FEMS Immunol. Med. Microbiol. \n                           56, 253\u2013259 (2009).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"173_CR20","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1128\/IAI.00285-07","volume":"75","author":"S Arjcharoen","year":"2007","unstructured":"Arjcharoen, S. et al. Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival. Infect. Immun. \n                           75, 4298\u20134304 (2007).","journal-title":"Infect. Immun."},{"key":"173_CR21","doi-asserted-by":"publisher","first-page":"e81617","DOI":"10.1371\/journal.pone.0081617","volume":"8","author":"N Chantratita","year":"2013","unstructured":"Chantratita, N. et al. Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide. PLoS ONE \n                           8, e81617 (2013).","journal-title":"PLoS. ONE"},{"key":"173_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1086\/520441","volume":"29","author":"C Charuchaimontri","year":"1999","unstructured":"Charuchaimontri, C. et al. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin. Infect. Dis. 29, 813\u2013818 (1999).","journal-title":"Clin. Infect. Dis"},{"key":"173_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1155\/1994\/856850","volume":"5","author":"LE Bryan","year":"1994","unstructured":"Bryan, L. E., Wong, D., Woods, D. E., Dance, D. A. & Chaowagul, W. Passive protection if diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can. J. Infect. Dis. \n                           5, 170\u2013178 (1994).","journal-title":"Can. J. Infect. Dis."},{"key":"173_CR24","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/iai.65.9.3648-3653.1997","volume":"65","author":"M Ho","year":"1997","unstructured":"Ho, M. et al. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. \n                           65, 3648\u20133653 (1997).","journal-title":"Infect. Immun."},{"key":"173_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1099\/0022-1317-51-12-1055","volume":"51","author":"SM Jones","year":"2002","unstructured":"Jones, S. M., Ellis, J. F., Russell, P., Griffin, K. F. & Oyston, P. C. F. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J. Med. Microbiol. \n                           51, 1055\u20131062 (2002).","journal-title":"J. Med. Microbiol."},{"key":"173_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1128\/IAI.74.3.1958-1961.2006","volume":"74","author":"SR Trevi\u00f1o","year":"2006","unstructured":"Trevi\u00f1o, S. R. et al. Monoclonal antibodies passively protect BALB\/c mice against Burkholderia mallei aerosol challenge. Infect. Immun. \n                           74, 1958\u20131961 (2006).","journal-title":"Infect. Immun."},{"key":"173_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1128\/CVI.00533-10","volume":"18","author":"S Zhang","year":"2011","unstructured":"Zhang, S. et al. In vitro and in vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei. Clin. Vaccine Immunol. \n                           18, 825\u2013834 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"173_CR28","doi-asserted-by":"publisher","first-page":"e35386","DOI":"10.1371\/journal.pone.0035386","volume":"7","author":"DP AuCoin","year":"2012","unstructured":"AuCoin, D. P. et al. Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei. PLoS ONE \n                           7, e35386 (2012).","journal-title":"PLoS ONE"},{"key":"173_CR29","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1099\/jmm.0.45766-0","volume":"53","author":"M Nelson","year":"2004","unstructured":"Nelson, M. et al. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J. Med. Microbiol. \n                           53, 1177\u20131182 (2004).","journal-title":"J. Med. Microbiol."},{"key":"173_CR30","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1016\/j.vaccine.2010.08.058","volume":"28","author":"SA Ngugi","year":"2010","unstructured":"Ngugi, S. A. et al. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Vaccine \n                           28, 7551\u20137555 (2010).","journal-title":"Vaccine"},{"key":"173_CR31","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/iai.64.7.2824-2828.1996","volume":"64","author":"PJ Brett","year":"1996","unstructured":"Brett, P. J. & Woods, D. E. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect. Immun. \n                           64, 2824\u20132828 (1996).","journal-title":"Infect. Immun."},{"key":"173_CR32","first-page":"148","volume":"2","author":"M Burtnick","year":"2012","unstructured":"Burtnick, M., Heiss, C., Schuler, A., Azadi, P. & Brett, P. Development of novel O-polysaccharide based glycoconjugates for immunization against glanders. Front. Cell Infect. Microbiol. \n                           2, 148 (2012).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"173_CR33","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1128\/IAI.01847-14","volume":"82","author":"AE Scott","year":"2014","unstructured":"Scott, A. E. et al. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis. Infect. Immun. \n                           82, 3206\u20133213 (2014).","journal-title":"Infect. Immun."},{"key":"173_CR34","doi-asserted-by":"publisher","unstructured":"Scott, A. E. et al. Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate. J. Immunol. Res. 2014, doi:10.1155\/2011\/392170 (2014).","DOI":"10.1155\/2011\/392170"},{"key":"173_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.nano.2014.08.005","volume":"11","author":"AE Gregory","year":"2015","unstructured":"Gregory, A. E. et al. A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei. Nanomedicine \n                           11, 447\u2013456 (2015).","journal-title":"Nanomedicine"},{"key":"173_CR36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.vaccine.2014.11.057","volume":"33","author":"AG Torres","year":"2015","unstructured":"Torres, A. G. et al. Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine. Vaccine \n                           33, 686\u2013692 (2015).","journal-title":"Vaccine"},{"key":"173_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fmicb.2014.00381","volume":"5","author":"F Garcia-Quintanilla","year":"2014","unstructured":"Garcia-Quintanilla, F., Iwashkiw, J. A., Price, N. L., Stratilo, C. & Feldman, M. F. Production of a recombinant vaccine canddiate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery. Front. Microbiol \n                           5, 381 (2014).","journal-title":"Front. Microbiol"},{"key":"173_CR38","doi-asserted-by":"publisher","first-page":"e0132032","DOI":"10.1371\/journal.pone.0132032","volume":"10","author":"DA Moustafa","year":"2015","unstructured":"Moustafa, D. A. et al. Recombinant Salmonella expressing Burkholderia mallei LPS O antigen provides protection in a murine model of melioidosis and glanders. PLoS ONE \n                           10, e0132032 (2015).","journal-title":"PLoS ONE"},{"key":"173_CR39","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1128\/CVI.00472-08","volume":"16","author":"V Novem","year":"2009","unstructured":"Novem, V. et al. Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Clin. Vaccine Immunol. 16, 1420\u20131428 (2009).","journal-title":"Clin. Vaccine Immunol"},{"key":"173_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0008-6215(00)90930-3","volume":"233","author":"YA Knirel","year":"1992","unstructured":"Knirel, Y. A. et al. Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides. Carbohydr. Res. \n                           233, 185\u2013193 (1992).","journal-title":"Carbohydr. Res."},{"key":"173_CR41","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/iai.63.9.3348-3352.1995","volume":"63","author":"MB Perry","year":"1995","unstructured":"Perry, M. B., MacLean, L. L., Schollaardt, T., Bryan, L. E. & Ho, M. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect. Immun. \n                           63, 3348\u20133352 (1995).","journal-title":"Infect. Immun."},{"key":"173_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/JB.184.3.849-852.2002","volume":"184","author":"MN Burtnick","year":"2002","unstructured":"Burtnick, M. N., Brett, P. J. & Woods, D. E. Molecular and physical characterization of Burkholderia mallei O antigens. J. Bacteriol. 184, 849\u2013852 (2002).","journal-title":"J. Bacteriol"},{"key":"173_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1574-6968.2003.tb11536.x","volume":"218","author":"PJ Brett","year":"2003","unstructured":"Brett, P. J., Burtnick, M. N. & Woods, D. E. The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis. FEMS Microbiol. Lett. \n                           218, 323\u2013328 (2003).","journal-title":"FEMS Microbiol. Lett."},{"key":"173_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.carres.2012.09.027","volume":"363","author":"C Heiss","year":"2012","unstructured":"Heiss, C., Burtnick, M. N., Black, I., Azadi, P. & Brett, P. J. Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264. Carbohydr. Res. \n                           363, 23\u201328 (2012).","journal-title":"Carbohydr. Res."},{"key":"173_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.carres.2013.08.013","volume":"381","author":"C Heiss","year":"2013","unstructured":"Heiss, C. et al. Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei. Carbohydr. Res. \n                           381, 6\u201311 (2013).","journal-title":"Carbohydr. Res."},{"key":"173_CR46","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1128\/IAI.02785-14","volume":"83","author":"C Wikraiphat","year":"2015","unstructured":"Wikraiphat, C. et al. Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation of O-polysaccharide modification. Infect. Immun. \n                           83, 2127\u20132138 (2015).","journal-title":"Infect. Immun."},{"key":"173_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1128\/IAI.01023-10","volume":"79","author":"PJ Brett","year":"2011","unstructured":"Brett, P. J. et al. Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides. Infect. Immun. \n                           79, 961\u2013969 (2011).","journal-title":"Infect. Immun."},{"key":"173_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/anie.198007311","volume":"19","author":"RR Schmidt","year":"1980","unstructured":"Schmidt, R. R. & Michel, J. Facile synthesis of \u03b1- and \u03b2-O-glycosyl imidates; preparation of glycosides and disaccharides. Angew. Chem. Int. Ed. Engl. \n                           19, 731\u2013732 (1980).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"173_CR49","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C3OB42586J","volume":"12","author":"C Gauthier","year":"2014","unstructured":"Gauthier, C. et al. Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity. Org. Biomol. Chem. \n                           12, 4218\u20134232 (2014).","journal-title":"Org. Biomol. Chem."},{"key":"173_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0040-4020(01)96443-9","volume":"41","author":"S David","year":"1985","unstructured":"David, S. & Hanessian, S. Regioselective manipulation of hydroxyl groups via organotin derivatives. Tetrahedron \n                           41, 643\u2013663 (1985).","journal-title":"Tetrahedron"},{"key":"173_CR51","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1016\/S0040-4039(00)97609-3","volume":"31","author":"P Konradsson","year":"1990","unstructured":"Konradsson, P., Udodong, U. E. & Fraser-Reid, B. Iodonium promoted reactions of disarmed thioglycosides. Tetrahedron Lett. \n                           31, 4313\u20134316 (1990).","journal-title":"Tetrahedron Lett."},{"key":"173_CR52","doi-asserted-by":"publisher","first-page":"C6","DOI":"10.1016\/S0008-6215(00)90163-0","volume":"155","author":"S Sato","year":"1986","unstructured":"Sato, S., Mori, M., Ito, Y. & Ogawa, T. An efficient approach to O-glycosides through CuBr2-Bu4NBr mediated activation of glycosides. Carbohydr. Res. \n                           155, C6\u2013C10 (1986).","journal-title":"Carbohydr. Res."},{"key":"173_CR53","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1021\/ja00847a032","volume":"97","author":"RU Lemieux","year":"1975","unstructured":"Lemieux, R. U., Hendriks, K. B., Stick, R. V. & James, K. Halide ion catalyzed glycosidation reactions. Syntheses of \u03b1-linked disaccharides. J. Am. Chem. Soc. \n                           97, 4056\u20134062 (1975).","journal-title":"J. Am. Chem. Soc."},{"key":"173_CR54","doi-asserted-by":"publisher","first-page":"C9","DOI":"10.1016\/S0008-6215(00)90385-9","volume":"149","author":"P F\u00fcgedi","year":"1986","unstructured":"F\u00fcgedi, P. & Garegg, P. J. A novel promoter for the efficient construction of 1,2-trans linkages in glycoside synthesis, using thioglycosides as glycosyl donors. Carbohydr. Res. \n                           149, C9\u2013C12 (1986).","journal-title":"Carbohydr. Res."},{"key":"173_CR55","doi-asserted-by":"publisher","first-page":"13926","DOI":"10.1021\/ja2062715","volume":"133","author":"C Gouliaras","year":"2011","unstructured":"Gouliaras, C., Lee, D., Chan, L. & Taylor, M. S. Regioselective activation of glycosyl acceptors by a diarylborinic acid-derived catalyst. J. Am. Chem. Soc. \n                           133, 13926\u201313929 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"173_CR56","doi-asserted-by":"publisher","first-page":"9790","DOI":"10.3390\/molecules17089790","volume":"17","author":"JK Fairweather","year":"2012","unstructured":"Fairweather, J. K., Liu, L., Karoli, T. & Ferro, V. Synthesis of disaccharides containing 6-deoxy-\u03b1-L-talose as potential heparan sulfate mimetics. Molecules \n                           17, 9790\u20139802 (2012).","journal-title":"Molecules"},{"key":"173_CR57","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1002\/ejoc.201403074","volume":"2014","author":"TG Frihed","year":"2014","unstructured":"Frihed, T. G., Pedersen, C. M. & Bols, M. Synthesis of all eight stereoisomeric 6-deoxy-L-hexopyranosyl donors \u2013 trends in using stereoselective reductions or Mitsunobu epimerizations. Eur. J. Org. Chem. \n                           2014, 7924\u20137939 (2014).","journal-title":"Eur. J. Org. Chem."},{"key":"173_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0008-6215(00)81193-3","volume":"16","author":"AF Bochkov","year":"1971","unstructured":"Bochkov, A. F. et al. Rigid conformation of tricyclic orthoesters of sugars. Carbohydr. Res. \n                           16, 497\u2013499 (1971).","journal-title":"Carbohydr. Res."},{"key":"173_CR59","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1039\/c1cc11680k","volume":"47","author":"Y Ma","year":"2011","unstructured":"Ma, Y., Lian, G., Li, Y. & Yu, B. Identification of 3,6-di-O-acetyl-1,2,4-O-orthoacetyl-\u03b1-D-glucopyranose as a direct evidence for the 4-O-acyl group participation in glycosylation. Chem. Commun. \n                           47, 7515\u20137517 (2011).","journal-title":"Chem. Commun."},{"key":"173_CR60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1039\/b000873g","volume":"2000","author":"T Bamhaoud","year":"2000","unstructured":"Bamhaoud, T., Sanchez, S. & Prandi, J. 1,2,5-Ortho esters of D-arabinose as versatile arabinofuranosidic building blocks. Concise synthesis of the tetrasaccharidic cap of the lipoarabinomannan of Mycobacterium tuberculosis. Chem. Commun. \n                           2000, 659\u2013660 (2000).","journal-title":"Chem. Commun."},{"key":"173_CR61","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1002\/1099-0690(200211)2002:22<3864::AID-EJOC3864>3.0.CO;2-8","volume":"2002","author":"S Sanchez","year":"2002","unstructured":"Sanchez, S., Bamhaoud, T. & Prandi, J. Elaboration of monoarabinofuranosidic building blocks. Eur. J. Org. Chem. 2002, 3864\u20133873 (2002).","journal-title":"Eur. J. Org. Chem"},{"key":"173_CR62","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.carres.2010.04.009","volume":"345","author":"X Cai","year":"2010","unstructured":"Cai, X. et al. Efficient synthesis of a 6-deoxytalose tetrasaccharide related to the antigenic O-polysaccharide produced by Aggregatibacter actinomycetemcomitans serotype c. Carbohydr. Res. \n                           345, 1230\u20131234 (2010).","journal-title":"Carbohydr. Res."},{"key":"173_CR63","doi-asserted-by":"publisher","first-page":"e00136","DOI":"10.1128\/mBio.00136-11","volume":"2","author":"DE Nuti","year":"2011","unstructured":"Nuti, D. E. et al. Identification of circulating bacterial antigens by in vivo microbial antigen discovery. MBio \n                           2, e00136\u201300111 (2011).","journal-title":"MBio"},{"key":"173_CR64","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1039\/C4MD00088A","volume":"5","author":"B Brogioni","year":"2014","unstructured":"Brogioni, B. & Berti, F. Surface plasmon resonance for the characterization of bacterial polysaccharide antigens: a review. Med. Chem. Commun. \n                           5, 1058\u20131066 (2014).","journal-title":"Med. Chem. Commun."},{"key":"173_CR65","first-page":"274","volume":"5","author":"R Marchetti","year":"2016","unstructured":"Marchetti, R. et al. \u201cRules of engagement\u201d of protein\u2013glycoconjugate interactions: a molecular view achievable by using NMR spectroscopy and molecular modelling. Chem. Open \n                           5, 274\u2013296 (2016).","journal-title":"Chem. Open"},{"key":"173_CR66","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1021\/acschembio.5b00502","volume":"10","author":"R Marchetti","year":"2015","unstructured":"Marchetti, R. et al. Burkholderia pseudomallei capsular polysaccharide recognition by a monoclonal antibody reveals key details toward a biodefense vaccine and diagnostics against melioidosis. ACS Chem. Biol. \n                           10, 2295\u20132302 (2015).","journal-title":"ACS Chem. Biol."},{"key":"173_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mrc.2041","volume":"45","author":"P Groves","year":"2007","unstructured":"Groves, P. et al. Temperature dependence of ligand-protein complex formation as reflected by saturation transfer difference NMR experiments. Magn. Reson. Chem. \n                           45, 745\u2013748 (2007).","journal-title":"Magn. Reson. Chem."},{"key":"173_CR68","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.1038\/ncomms11224","volume":"7","author":"F Broecker","year":"2016","unstructured":"Broecker, F. et al. Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nat. Commun. \n                           7, 11224 (2016).","journal-title":"Nat. Commun."},{"key":"173_CR69","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1073\/pnas.0401351101","volume":"101","author":"TR Kozel","year":"2004","unstructured":"Kozel, T. R. et al. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl Acad. Sci. USA \n                           101, 5042\u20135047 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"173_CR70","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1128\/JCM.02856-15","volume":"54","author":"V Suttisunhakul","year":"2016","unstructured":"Suttisunhakul, V. et al. Development of rapid enzyme-linked immunosorbent assays for detection of antibodies to Burkholderia pseudomallei. J. Clin. Microbiol. \n                           54, 1259\u20131268 (2016).","journal-title":"J. Clin. Microbiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00173-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T19:21:18Z","timestamp":1671736878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00173-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-00173-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"assertion":[{"value":"15 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}